A comparison of regular salmeterol vs ‘as required’ salbutamol therapy in asthmatic children
- 28 February 1998
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 92 (2), 292-299
- https://doi.org/10.1016/s0954-6111(98)90112-3
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Perspectives in β2-agonist therapy: Vox clamantis in deserto vel lux in tenebris?*Journal of Allergy and Clinical Immunology, 1995
- Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients.Thorax, 1993
- Do bronchodilators adversely affect the prognosis of bronchial hyperresponsiveness?Thorax, 1993
- Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.Thorax, 1993
- Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic childrenJournal of Allergy and Clinical Immunology, 1993
- Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthmaJournal of Allergy and Clinical Immunology, 1992
- The Use of β-Agonists and the Risk of Death and near Death from AsthmaNew England Journal of Medicine, 1992
- Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthmaJournal of Allergy and Clinical Immunology, 1987
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Bronchodilator drugsPharmacology & Therapeutics, 1982